2009 Atherosclerosis Gordon Research Conference

2009年动脉粥样硬化戈登研究会议

• 批准号: 7669740
• 负责人: Martha K Cathcart
• 金额: $ 1.5万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7669740
• 关键词: Area; Arterial Fatty Streak; Atherosclerosis; Biology; Blood Vessels; Cardiovascular Diseases; Cause of Death; Cell Lineage; Chronic; Complex; Country; Development; Diabetes Mellitus; Diagnostic; Discipline; Disease; Etiology; Future; Genetic; Genomics; Heterogeneity; Inflammation; Inflammatory; Knowledge; Lesion; Lipids; Lipoproteins; Minority; New Hampshire; Participant; Public Health; Qualifying; Research; Resolution; Resources; Schools; Scientist; Stem cells; Systems Biology; Technology; Therapeutic; Ursidae Family; Vascular Diseases; Woman; abstracting; career; frontier; macrophage; meetings; posters; stem cell biology; symposium

DESCRIPTION (provided by applicant): The 19th Gordon Research Conference on Atherosclerosis will be held at Tilton School in Tilton, New Hampshire on June 21-26, 2009. This conference has been held every two years since 1973. The conference enjoys a worldwide reputation, and brings together highly qualified participants from all levels of career status and from a variety of backgrounds for "off-the-record," high quality intensive discussions of research at the frontiers of knowledge in atherosclerosis. This integrative conference has been particularly valuable in atherosclerosis research because of the multiple and distinct disciplines that bear on the origin and progression of this complex, multifaceted disease. The Atherosclerosis Gordon Conference will provide an overview of the most important recent developments in the pathobiology of atherosclerosis. The meeting will discuss all aspects of atherosclerotic lesion development, progression and resolution as well as current and future therapeutic approaches. Throughout, special emphasis will be placed on cutting edge technologies and resources that are relevant to the study of atherosclerosis. Nine sessions are planned and will cover the following topics: 1. Macrophage heterogeneity; 2. Systems biology of atherosclerosis; 3. Genomics and genetics of atherosclerosis; 4. Stem cells and lineage acquisition; 5. Lesion dynamics and calcific vasculopathy; 6. Lipids, lipoproteins and dysmetabolic conditions; 7. Lesion reversibility; 8. Chronicity of inflammation; 9. Future therapeutics and diagnostics. The conference will be a major vehicle for the integration of new knowledge in the field of atherosclerosis research. In order to stimulate an interdisciplinary dialogue, speakers will be invited who represent distinct but overlapping areas of research such as; stem cell biology, genomics, lipoproteins, diabetes and vascular biology. The conference will encourage the participation of women and minorities. Some of the invited speakers will be junior scientists and participation of junior scientists and trainees will also be encouraged through poster sessions. The conference will provide a comprehensive overview of current research on atherosclerosis with a focus on the latest and most exciting developments in the field and future therapeutic approaches. (End of Abstract)

描述（由申请人提供）： 第19届戈登动脉粥样硬化研究会议将于2009年6月21日至26日在新罕布什尔州蒂尔顿的蒂尔顿学校举行。这次会议自1973年以来每两年举行一次。会议享有全球声誉，并召集了来自各种职业地位的高素质参与者，从各种各样的背景中进行了“优质的研究”，这是一项高质量的研究。这次综合会议在动脉粥样硬化研究中特别有价值，因为这种复杂，多方面疾病的起源和进展有多个和不同的学科。动脉粥样硬化戈登会议将概述动脉粥样硬化病理生物学的最新发展。会议将讨论动脉粥样硬化病变发育，进展和解决方案以及当前和未来的治疗方法的各个方面。在整个过程中，将特别重点放在与动脉粥样硬化研究有关的尖端技术和资源上。计划了九次会议，并将涵盖以下主题：1。巨噬细胞异质性； 2。动脉粥样硬化的系统生物学； 3。动脉粥样硬化的基因组学和遗传学； 4。干细胞和谱系采集； 5。病变动力学和钙化血管病； 6。脂质，脂蛋白和非代谢疾病； 7。病变可逆性； 8。炎症的慢性； 9。未来的治疗和诊断。该会议将是在动脉粥样硬化研究领域融合新知识的主要工具。为了刺激跨学科的对话，将邀请演讲者代表不同但重叠的研究领域，例如；干细胞生物学，基因组学，脂蛋白，糖尿病和血管生物学。会议将鼓励妇女和少数民族的参与。一些受邀的演讲者将是初级科学家，而初级科学家和学员的参与也将通过海报会议来鼓励。该会议将对当前有关动脉粥样硬化的研究的全面概述，重点关注该领域最新，最令人兴奋的发展以及未来的治疗方法。 （抽象的结尾）